Imagin Diagnostic Centres

Imagin Diagnostic Centres, Inc. (Imagin) has a unique investment strategy for the development of diagnostic molecular imaging commencing globally in Canada. Imagin through strategic acquisitions in the PET scan centres, Positron Emitting Radiopharmaceuticals (PER’s) and PET equipment businesses is well-positioned to make a significant positive impact to worldwide molecular medicine and critical disease. Critical disease is defined as cancer, heart disease and neurological disorders such as Alzheimer’s and Parkinson’s disease. PET scan technology is essential in the diagnosis, staging and treatment planning for critical disease.

Most Recent Updates:

Press Releases: June 12, 2008
News: July 7, 2008
Need a PET Scan?: CareImaging PET Scan Clinic